DEA Archived Press Releases

Press Releases before January 20, 2025
35 Results - Showing 1 to 10
PRESS RELEASE

13 Additional Defendants Charged in Fentanyl Distribution Network that Spanned from California to D.C.

WASHINGTON – Federal and local law enforcement announced the arrests of 11 more alleged members of a fentanyl drug distribution network responsible for bringing hundreds of thousands of fake Oxycodone (M30) pills from California to D.C. Today's announcement was made by DEA Administrator Anne Milgram, U.S. Attorney Matthew M. Graves...
PRESS RELEASE

DEA’s National Prescription Drug Take Day Removes Almost 600,000 Pounds of Unneeded Prescription Medications Across the Country

WASHINGTON – On Oct. 28, 2023, the community once again emptied their medicine cabinets to help dispose of old, unwanted, and expired medications. Nationwide, DEA and its law enforcement partners collected 599,897 pounds of unneeded medications at 4,675 collection sites nationwide. For more than a decade, DEA’s National Prescription Take...
PRESS RELEASE

DEA Rocky Mountain Division Removes 18,500 Pounds of Unneeded Prescription Medications on Drug Take Back Day

DENVER – On Oct. 28, 2023, the community once again emptied their medicine cabinets to help dispose of old, unwanted, and expired medications. Nationwide, DEA and its law enforcement partners collected 599,897 pounds of unneeded medications at 4,675 collection sites. The Rocky Mountain Field Division collected just over 18,500 pounds...
PRESS RELEASE

Members of Mexican Cartel Pipeline Indicted on Charges of Distributing Large Quantities of Fentanyl in Adams County

Brighton, CO — Today, the DEA Rocky Mountain Field Division joined Colorado's 17th Judicial District Attorney Brian Mason, the Drug Trafficking Unit of the Adams County DA's Office, and the North Metro Task Force to announce grand jury indictments against nine people accused of funneling fentanyl, methamphetamine, and cocaine into...
PRESS RELEASE

DEA Executes Operation Bottleneck to Prevent the Diversion of Controlled Substances and Keep Communities Safe

WASHINGTON – Today, the U.S. Drug Enforcement Administration announced administrative actions against six DEA-registered companies which, together, failed to account for more than a million doses of opioids. Under DEA initiative “Operation Bottleneck,” DEA served an Immediate Suspension Order and five Orders to Show Cause over a one-month period from...
PRESS RELEASE

DEA Hosts 25th National Prescription Drug Take Back Day

WASHINGTON, DC – The Drug Enforcement Administration will host its 25th National Prescription Drug Take Back Day on Saturday, October 28, from 10 a.m. to 2 p.m. This event offers an easy, no-cost opportunity for the community to anonymously dispose of unneeded medications at nearly 5,000 local drop-off locations nationwide...
PRESS RELEASE

First Regional Family Summit on Fentanyl Held in Utah

SALT LAKE CITY – On October 19, the Drug Enforcement Administration’s Rocky Mountain Field Division, in partnership with the State of Utah’s Office of the Attorney General and with the support of the United States Attorney’s Office for the District of Utah, hosted a Family Summit for those who have...
PRESS RELEASE

DEA Holds Second Annual Family Summit on Fentanyl

WASHINGTON – On September 25 and 26, the U.S. Drug Enforcement Administration hosted the second annual DEA Family Summit on Fentanyl for families from across the country who have experienced the profound loss of a child due to a drug poisoning. U.S. Attorney General Merrick B. Garland and DEA Administrator...
PRESS RELEASE

DEA Recognizes National Fentanyl Prevention and Awareness Day with Extended Hours for the Faces of Fentanyl Exhibit

WASHINGTON – The Drug Enforcement Administration recognizes National Fentanyl Prevention and Awareness Day by joining the dedicated voices who continue to raise awareness in an effort to prevent the fentanyl poisonings devastating families across the country. On Monday, August 21 the DEA Museum will open with extended hours from 6...
PRESS RELEASE

DEA Hosts Public Listening Sessions on Telemedicine Regulations

WASHINGTON – The Drug Enforcement Administration will host public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. The listening sessions will be held in person and livestreamed with remote participation available...